Everads Therapy
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Everads Injector in Suprachoroidal Administration of TA Suspension, for Treatment of Patients With DME (NCT06314217) | Everads Therapy | 2024-02-18 |
Track Everads Therapy automatically
Every clearance here is in the API, with alerts when new ones post.